Effect of Vitamin E and Selenium Supplement on Paraoxonase-1 Activity, Oxidized Low Density Lipoprotein and Antioxidant Defense in Diabetic Rats

Overview

Journal Bioimpacts

Specialty Biomedical Engineering

Date 2013 May 17

PMID 23678416

Citations 10

Authors

Tayibeh Ghaffari

Mohammad Nouri

Ebrahim Irannejad

Mohammad-Reza Rashidi

Affiliations

Soon will be listed here.

Abstract

Introduction: The aim of the present study was to assess the effects of vitamin E and selenium supplementation on serum paraoxonase (PON1) activity, lipid peroxidation and antioxidant defense in streptozotocin-induced diabetic rats.

Methods: Thirty two female Sprague Dawley rats were divided into 3 groups: the control group (n=8) received a standard diet; streptozotocin (STZ)-induced diabetic rats (n=12), received corn oil and physiological solution; and vitamin E and selenium supplemented diabetic rats (n=12) were treated with oral administration of vitamin E (300 mg/kg) and sodium selenite (0.5 mg/kg) once a day for 4 weeks.

Results: Significantly lower total antioxidant status (TAS), PON1and erythrocyte SOD activities and a higher fasting plasma glucose level were observed in the diabetic rats compared to the control. A significant increase in SOD and GPX activities in vitamin E and selenium supplemented diabetic group was observed after 5 weeks of the experiment. Compared to the normal rats, malondialdehyde (MDA) and oxidized LDL (Ox-LDL) levels were higher in the diabetic animals; however, these values reduced significantly following vitamin E and selenium supplementation.

Conclusion: Vitamin E and selenium supplementation in diabetic rats has hypolipidemic, hypoglycemic and antioxidative effects and may slow down the progression of diabetic complications through its protective effect on PON1 activity and lipoproteins oxidation.

Citing Articles

Protective effects of paraoxonase-1, vitamin E and selenium, and oxidative stress index on the susceptibility of low density lipoprotein to oxidation in diabetic patients with/without coronary artery disease.

Mehvari F, Imanparast F, Mohaghegh P, Alimoradian A, Khansari N, Ansari Asl B Eur J Med Res. 2023; 28(1):300.

PMID: 37635255 PMC: 10464334. DOI: 10.1186/s40001-023-01254-9.

The inhibitory effect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor.

da Silva Junior C, Junior C, Pereira E, Binda N, da Silva J, Cordeiro M Pharmacol Rep. 2020; 72(1):47-54.

PMID: 32016848 DOI: 10.1007/s43440-019-00002-3.

DIBc, a nanochelating-based nano metal-organic framework, shows anti-diabetic effects in high-fat diet and streptozotocin-induced diabetic rats.

Fakharzadeh S, Kalanaky S, Hafizi M, Nazaran M, Zardooz H Int J Nanomedicine. 2019; 14:2145-2156.

PMID: 30988614 PMC: 6443220. DOI: 10.2147/IJN.S196050.

Effects of selenium supplementation on paraoxonase-1 and myeloperoxidase activity in subjects with cardiovascular disease: the Selenegene study, a double-blind randomized controlled trial.

MirmohammadSadeghi A, Gharipour M, Roohafza H, Dianatkhah M, Sadeghi M Arch Med Sci Atheroscler Dis. 2019; 3:e112-e118.

PMID: 30775600 PMC: 6374566. DOI: 10.5114/amsad.2018.77820.

Role of glutathione peroxidase 1 in glucose and lipid metabolism-related diseases.

Huang J, Zhou J, Wu Y, Ren F, Lei X Free Radic Biol Med. 2018; 127:108-115.

PMID: 29800654 PMC: 6168395. DOI: 10.1016/j.freeradbiomed.2018.05.077.

References

Maritim A, Sanders R, Watkins 3rd J . Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003; 17(1):24-38. DOI: 10.1002/jbt.10058. View

Paglia D, Valentine W . Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 70(1):158-69. View

Mosca L, Banka C, Benjamin E, Berra K, Bushnell C, Dolor R . Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007; 115(11):1481-501. DOI: 10.1161/CIRCULATIONAHA.107.181546. View

Chait A, Brazg R, Tribble D, Krauss R . Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med. 1993; 94(4):350-6. DOI: 10.1016/0002-9343(93)90144-e. View

Wu J, Ward N, Indrawan A, Almeida C, Hodgson J, Proudfoot J . Effects of alpha-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes. Clin Chem. 2007; 53(3):511-9. DOI: 10.1373/clinchem.2006.076992. View

Mackness M, Arrol S, Abbott C, Durrington P . Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 1993; 104(1-2):129-35. DOI: 10.1016/0021-9150(93)90183-u. View

Bergmeier C, Siekmeier R, Gross W . Distribution spectrum of paraoxonase activity in HDL fractions. Clin Chem. 2004; 50(12):2309-15. DOI: 10.1373/clinchem.2004.034439. View

Yanardag R, Ozsoy-Sacan O, Ozdil S, Bolkent S . Combined effects of vitamin C, vitamin E, and sodium selenate supplementation on absolute ethanol-induced injury in various organs of rats. Int J Toxicol. 2007; 26(6):513-23. DOI: 10.1080/10915810701707296. View

Selvakumar E, Prahalathan C, Mythili Y, Varalakshmi P . Beneficial effects of DL-alpha-lipoic acid on cyclophosphamide-induced oxidative stress in mitochondrial fractions of rat testis. Chem Biol Interact. 2005; 152(1):59-66. DOI: 10.1016/j.cbi.2005.01.009. View

10.

Kondo A, Manabe M, Saito K, Maekawa M, Kanno T . Insulin treatment prevents LDL from accelerated oxidation in patients with diabetes. J Atheroscler Thromb. 2003; 9(6):280-7. DOI: 10.5551/jat.9.280. View

11.

Mahay S, Adeghate E, Lindley M, Rolph C, Singh J . Streptozotocin-induced type 1 diabetes mellitus alters the morphology, secretory function and acyl lipid contents in the isolated rat parotid salivary gland. Mol Cell Biochem. 2004; 261(1-2):175-81. DOI: 10.1023/b:mcbi.0000028753.33225.68. View

12.

Bleys J, Navas-Acien A, Guallar E . Serum selenium and diabetes in U.S. adults. Diabetes Care. 2007; 30(4):829-34. DOI: 10.2337/dc06-1726. View

13.

Al-Shamsi M, Amin A, Adeghate E . Vitamin E ameliorates some biochemical parameters in normal and diabetic rats. Ann N Y Acad Sci. 2006; 1084:411-31. DOI: 10.1196/annals.1372.033. View

14.

Jakubowski H . Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J Biol Chem. 2000; 275(6):3957-62. DOI: 10.1074/jbc.275.6.3957. View

15.

Inoue T, Uchida T, Kamishirado H, Takayanagi K, Hayashi T, Morooka S . Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol. 2001; 37(3):775-9. DOI: 10.1016/s0735-1097(00)01199-2. View

16.

DRABKIN D . THE MOLECULAR WEIGHT OF HAEMOGLOBIN, ITS IRON AND NITROGEN CONTENT AND OPTICAL PROPERTIES--THEIR RELEVANCE IN THE PROBLEM OF A REFERENCE STANDARD FOR HAEMOGLOBIN MEASUREMENT. Bibl Haematol. 1965; 21:33-42. DOI: 10.1159/000428151. View

17.

Ikeda Y, Suehiro T, Inoue M, Nakauchi Y, Morita T, Arii K . Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus. Metabolism. 1998; 47(5):598-602. DOI: 10.1016/s0026-0495(98)90246-3. View

18.

Will J, Ford E, Bowman B . Serum vitamin C concentrations and diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 1999; 70(1):49-52. DOI: 10.1093/ajcn/70.1.49. View

19.

Girona J, Manzanares J, Marimon F, Cabre A, Heras M, Guardiola M . Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients. Nutr Metab Cardiovasc Dis. 2007; 18(5):380-7. DOI: 10.1016/j.numecd.2007.04.002. View

20.

Sargeant L, Wareham N, Bingham S, Day N, Luben R, Oakes S . Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care. 2000; 23(6):726-32. DOI: 10.2337/diacare.23.6.726. View